Cargando…

iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors

BACKGROUND: Dozens of transplants generated from pluripotent stem cells are currently in clinical trials. The creation of patient-specific iPSCs makes personalized therapy possible due to their main advantage of immunotolerance. However, some reports have claimed recently that aberrant gene expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bogomiakova, Margarita E., Sekretova, Elizaveta K., Anufrieva, Ksenia S., Khabarova, Polina O., Kazakova, Anastasia N., Bobrovsky, Pavel A., Grigoryeva, Tatiana V., Eremeev, Artem V., Lebedeva, Olga S., Bogomazova, Alexandra N., Lagarkova, Maria A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088155/ https://www.ncbi.nlm.nih.gov/pubmed/37038186 http://dx.doi.org/10.1186/s13287-023-03308-5

Ejemplares similares

Cerebral Organoids—Challenges to Establish a Brain Prototype
por: Eremeev, Artem V., et al.
Publicado: (2021)

Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
por: Maddineni, Sainiteesh, et al.
Publicado: (2022)

Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Publicado: (2022)

Clinical Potential of Cellular Material Sources in the Generation of iPSC-Based Products for the Regeneration of Articular Cartilage
por: Eremeev, Artem, et al.
Publicado: (2023)

Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity
por: Flahou, Charlotte, et al.
Publicado: (2021)

Possible NK cell-mediated immune responses against iPSC-derived cells in allogeneic transplantation settings
por: Masuda, Kyoko, et al.
Publicado: (2021)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

iPSC-based modeling of helicase deficiency reveals impaired cell proliferation and increased apoptosis after NK cell lineage commitment
por: Seo, Seungmae, et al.
Publicado: (2023)

Possibilities for Using Pluripotent Stem Cells for Restoring Damaged Eye Retinal Pigment Epithelium
por: Kharitonov, A. E., et al.
Publicado: (2018)

Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
por: Cichocki, Frank, et al.
Publicado: (2023)

Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells
por: Meng, Fanyi, et al.
Publicado: (2023)

STIM2 Mediates Excessive Store-Operated Calcium Entry in Patient-Specific iPSC-Derived Neurons Modeling a Juvenile Form of Huntington's Disease
por: Vigont, Vladimir A., et al.
Publicado: (2021)

Electrolyte imbalance causes suppression of NK and T cell effector function in malignant ascites
por: Hrvat, Antonio, et al.
Publicado: (2023)

Morphological Characterization of Astrocytes in a Xenograft of Human iPSCDerived Neural Precursor Cells
por: Voronkov, D. N., et al.
Publicado: (2022)

NK cells and poxvirus infection
por: Burshtyn, Deborah N.
Publicado: (2013)

Identification of Human NK17/NK1 Cells
por: Pandya, Abhilash D., et al.
Publicado: (2011)

Ouabain-Induced Gene Expression Changes in Human iPSC-Derived Neuron Culture Expressing Dopamine and cAMP-Regulated Phosphoprotein 32 and GABA Receptors
por: Lopachev, Alexander V., et al.
Publicado: (2021)

NK-cell fratricide: Dynamic crosstalk between NK and cancer cells
por: Nakamura, Kyohei, et al.
Publicado: (2013)

The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
por: Yu, Yanlin
Publicado: (2023)

Generation and Characterization of Human Induced Pluripotent Stem Cells
por: Shutova, M.V., et al.
Publicado: (2009)

Unhurried NK cells
por: Van Epps, Heather L.
Publicado: (2006)

CAM and NK Cells
por: Takeda, Kazuyoshi, et al.
Publicado: (2004)

NK Cells and Psoriasis
por: Dunphy, Sinéad, et al.
Publicado: (2011)

NK Cell Exhaustion
por: Bi, Jiacheng, et al.
Publicado: (2017)

Migration of NK cells
por: Gismondi, Angela, et al.
Publicado: (2006)

NK cells and chemokines
por: Gismondi, Angela, et al.
Publicado: (2010)

NK-/T-cell lymphomas
por: Wang, Hua, et al.
Publicado: (2021)

Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets
por: Mace, Emily M., et al.
Publicado: (2016)

MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma
por: Gao, FengXia, et al.
Publicado: (2020)

TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality
por: Persyn, Eva, et al.
Publicado: (2022)

Advances in Understanding the Immune Imbalance between T-Lymphocyte Subsets and NK Cells in Recurrent Spontaneous Abortion
por: Zhao, Xiaoxuan, et al.
Publicado: (2018)

Epigenetic reprogramming by naïve conditions establishes an irreversible state of partial X chromosome reactivation in female stem cells
por: Panova, Alexandra V., et al.
Publicado: (2018)

Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
por: Barilà, Gregorio, et al.
Publicado: (2018)

Deeper insights into transcriptional features of cancer-associated fibroblasts: An integrated meta-analysis of single-cell and bulk RNA-sequencing data
por: Kazakova, Anastasia N., et al.
Publicado: (2022)

Homotypic NK cell-to-cell communication controls cytokine responsiveness of innate immune NK cells
por: Kim, Tae-Jin, et al.
Publicado: (2014)

The alternative protein isoform NK2B, encoded by the vnd/NK-2 proneural gene, directly activates transcription and is expressed following the start of cells differentiation
por: Stepchenko, Alexander G., et al.
Publicado: (2011)

Development of Murine Hepatic NK Cells during Ontogeny: Comparison with Spleen NK Cells
por: Wu, Xian, et al.
Publicado: (2012)

Exogenous activated NK cells enhance trafficking of endogenous NK cells to endometriotic lesions
por: Montenegro, Mary Lourdes, et al.
Publicado: (2015)

Promoting NK cell trafficking to improve therapeutic effect of NK cell therapy on osteosarcoma
por: Yang, Yuanzheng, et al.
Publicado: (2015)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
por: Wu, Xinyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_53hrksa7od2738i1f5qg218c5b